Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10832	Companies
235109	Keywords
164007	Articles
125891	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 01/22/2025 at 15:00, 1 year 6 months ago

Jaguar Health Announces First Patient Dosed in Investigator-Initiated Trial (IIT) Evaluating Crofelemer for the Rare Disease Indication of Microvillus Inclusion Disease (MVID), with Proof-of-Concept (POC) Data Potentially Available H1 2025
Sheikh Khalifa Medical City hosts Jaguar Health's crofelemer trial for MVID & SBS-IF. POC data aims to support early patient access in EU countries

Crofelemer Jaguar Health MVID SBS-IF Sheikh Khalifa Medical City
BRIEF

published on 01/10/2025 at 22:20, 1 year 7 months ago

Jaguar Health Announces Inducement Grants for New Employees

Jaguar Health Employee Grants Nasdaq Rule Stock Units RSU Vesting
BRIEF

published on 01/10/2025 at 22:20, 1 year 7 months ago

Jaguar Health annonce des subventions incitatives pour les nouveaux employés

Santé Jaguar Subventions Aux Employés Règle Du Nasdaq Unités En Stock Acquisition De RSU
PRESS RELEASE

published on 01/10/2025 at 22:15, 1 year 7 months ago

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jaguar Health, Inc. granted RSUs to new employees, with vesting over one to three years. The RSUs were approved by Jaguar's Compensation Committee

Restricted Stock Units Jaguar Health Vesting RSUs New Employees
BRIEF

published on 01/08/2025 at 14:35, 1 year 7 months ago

Jaguar Health to Present at Upcoming Investor Events

Biotech Showcase Pharmaceuticals Jaguar Health Fireside Chat Investor Events
BRIEF

published on 01/08/2025 at 14:35, 1 year 7 months ago

Jaguar Health participera aux prochains événements destinés aux investisseurs

Médicaments Santé Jaguar Discussion Au Coin Du Feu Vitrine Biotechnologique Événements Pour Les Investisseurs
PRESS RELEASE

published on 01/08/2025 at 14:30, 1 year 7 months ago

Jaguar Health Presenting January 13 at Lytham 2025 Investor Healthcare Summit & January 14 at Biotech Showcase
Jaguar Health, Inc. to participate in virtual fireside chat and in-person presentation at upcoming healthcare events. Focus on developing medicines from rainforest plants

Pharmaceuticals Jaguar Health Rainforest Plants Virtual Fireside Chat Healthcare Events
BRIEF

published on 01/07/2025 at 16:05, 1 year 7 months ago

Magdalena Biosciences Set to Present at Neuroscience Innovation Forum

ADHD Magdalena Biosciences Schizophrenia Botanical Drugs MB2500
BRIEF

published on 01/07/2025 at 16:05, 1 year 7 months ago

Magdalena Biosciences s'apprête à présenter son projet au Forum d'innovation en neurosciences

Médicaments Botaniques Schizophrénie Biosciences De Magdalena MB2500 TDAH
PRESS RELEASE

published on 01/07/2025 at 16:00, 1 year 7 months ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum
Magdalena plans to file IND for new psychoactive drug in 2025 for mental health, focusing on ADHD and schizophrenia. Potential paradigm shift in plant-based drug development

ADHD Schizophrenia IND Application Magdalena Psychoactive Drug

Accesswire

Published on 08/13/2026 at 19:55, 43 minutes ago

NuRAN Wireless Receives Nasdaq Approval to List on The Nasdaq Capital Market; Trading Expected to Commence August 17, 2026 and C$7.6 Million Financing to Close August 14, 2026
Published on 08/13/2026 at 17:55, 2 hours 43 minutes ago

Alset AI Announces Agreement to Sell 9.9% Interest in Lyken AI Computing to FingerMotion
Published on 08/13/2026 at 14:31, 6 hours 7 minutes ago

Wi2Wi Announces Strategic Equipment Investments to Expand Production Capacity
Published on 08/13/2026 at 14:15, 6 hours 23 minutes ago

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
Published on 08/13/2026 at 14:00, 6 hours 38 minutes ago

AEONIAN Expands Koocanusa Copper Project to Approximately 412 Km(2); Fieldwork Underway Across Four New Target Areas

View all ACCESSWIRE

EQS Group

Published on 08/13/2026 at 18:17, 2 hours 21 minutes ago

EQS-Adhoc: Energiekontor AG: Energiekontor adjusts earnings guidance for the 2026 financial year
Published on 08/13/2026 at 18:00, 2 hours 37 minutes ago

Issue of Equity
Published on 08/13/2026 at 18:00, 2 hours 38 minutes ago

Deutsche EuroShop reports good operational performance in the first half of 2026 and confirms its forecast
Published on 08/13/2026 at 17:50, 2 hours 47 minutes ago

EQS-Adhoc: NFON AG updates guidance for the 2026 financial year
Published on 08/13/2026 at 17:23, 3 hours 14 minutes ago

EQS-Adhoc: Sirma Group JSC: Signing of Agreements to Acquire a Majority Stake in Jucari Global Pty Ltd

Les Echos

Published on 08/13/2026 at 18:00, 2 hours 38 minutes ago

Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 2 days 2 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 2 days 2 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 3 days 2 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 3 days 2 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

View all LES ECHOS COMFI WIRE